Philips introduces next-generation Digital Pathology Suite - IntelliSite - to enhance diagnostic confidence and streamline pathology lab workflows
15 October 2021 - 07:00PM
October 15, 2021
- Solution offers high quality imaging with multi-site,
multi-disciplinary interoperability, artificial intelligence and
Laboratory Information System integration, enhancing diagnostic
confidence
- Scalable image management system caters to the needs of all
levels of pathology imaging
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced the launch of its next-generation digital pathology
solution, moving digital pathology into the heart of
enterprise-wide healthcare informatics. Philips Digital Pathology
Suite – IntelliSite – features a comprehensive, scalable suite of
software tools and capabilities designed to help streamline
workflows, enhance diagnostic confidence, facilitate team
collaboration, integrate artificial intelligence (AI) and increase
the efficiency of pathology labs.
Philips Digital Pathology Suite offers a range of solutions
designed for different use cases with an affordable cost of
ownership. From low-volume ‘spoke’ labs or small independent labs,
where small batches of slides are continually processed and
scanned, to medium and large labs operating high-volume batch
processing workflows. The hardware is also pre-equipped for
multi-layer slide scanning. Images are captured in a centralized
informatics platform that has been optimized around pathologists’
workflows, integrating with leading third-party AI tools and
algorithms with the aim to further reduce laboratory costs and
enhance diagnostic capabilities.
"Integrated diagnostic capabilities are a cornerstone to a
precise diagnosis and personalized care pathway selection for
oncology patients and only when data and specialties work together
in harmony can the ultimate promise of care be realized,” said
Louis Culot, General Manager Oncology Informatics at Philips.
“That’s why bringing together multiple pieces of the healthcare
continuum – like radiology, pathology, and genomics – is the key to
a new paradigm of diagnostic precision. By providing pathologists
the interoperability and connectivity to share high-quality images
and diagnostic insights across networks, Philips Digital Pathology
Suite positions them as key stakeholders in the data-driven
healthcare systems of the future.”
Digital Pathology Suite includes a range of three pathology
slide scanners, as well as Pathology Workspace – Image Management
System – a comprehensive set of software tools and capabilities
that encompass every stage of the digital pathology process,
including an advanced image management system, bidirectional
interoperability into laboratory information systems, and a case
viewer that facilitates multidisciplinary case reviews and care
pathway selection. Diagnostic confidence is enhanced by superb
image quality and advanced algorithms, such as automatic tissue
shape detection and non-rectangular optimization of regions of
interest. Vendor-agnostic data interoperability also allows the
easy sharing of patient-centric histology data across enterprises
and between sites.
“MEDIPATH is focused on accelerating the path of augmented
pathology by slide digitalization on all our technical platforms.
We are very excited to leverage the new Philips Digital Pathology
Suite, including the Pathology Scanner SG300 and Pathology
Workspace with de-identification tools, for each of our sites,”
said Stephane Rossat, Director for innovation, science and project
management at MEDIPATH, a French Pathology group with a network of
11 technical labs. “Following the first days of installation, the
solution is already proving easy to use, with images generated more
quickly, while the quality and sharpness of the images produced is
experienced to be superior. The Philips Digital Pathology Suite is
the solution that our organization needs to expand our digital
pathology capabilities and activate our transformation [1].”
Integrated intelligence and automation across smart
diagnostic systemsPrecision medicine has increased the
volume and complexity of workloads, with pathology labs worldwide
facing a shortage of skilled staff. Within the diagnosis and
staging of cancer, pathology information is combined with data from
multiple disciplines, including radiology, pathology and genomics,
to deliver the diagnostic precision required for highly
personalized care. There is an urgent need for solutions that
combine operational efficiency, team-working, expertise sharing,
and enterprise-wide informatics to make the most of a pathology
lab’s human resources.
Through breakthrough innovations and partnerships, Philips
integrates intelligence and automation into its Precision Diagnosis
portfolio, including smart diagnostic systems, integrated workflow
solutions with the aim to transform departmental operations,
advanced informatics that enhance diagnostic confidence, and care
pathway solutions that allow medical professionals to tailor
treatment to individual patients. By developing and integrating
AI-enabled applications, the company aims to enhance the ability to
turn data into actionable insights and drive the right care in the
right sequence at the right time.
Philips Digital Pathology Suite is being showcased at the
Pathology Visions 2021 event (October 17-19, Las Vegas, USA).
Follow @PhilipsLiveFrom for updates on Philips participation at the
event, and visit Philips Digital Pathology for more
information.
[1] Results of customer testimonies are not predictive of
results in other cases. Results in other cases may vary.
For further information, please contact:
Mark GrovesPhilips Global Press OfficeTel.: +31 631 639
916E-mail: mark.groves@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 17.3 billion and
employs approximately 77,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips Digital Pathology Suite
- Philips Pathology Scanner
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Feb 2024 to Mar 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Mar 2023 to Mar 2024